Cleared Traditional

Velacur (K223287) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K223287 · Sonic Incytes · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2023
Decision
177d
Days
Class 2
Risk

K223287 is an FDA 510(k) clearance for the Velacur. Classified as System, Imaging, Pulsed Echo, Ultrasonic (product code IYO), Class II - Special Controls.

Submitted by Sonic Incytes (Vancouver, CA). The FDA issued a Cleared decision on April 20, 2023 after a review of 177 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1560 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Sonic Incytes devices

Submission Details

510(k) Number K223287 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 25, 2022
Decision Date April 20, 2023
Days to Decision 177 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
70d slower than avg
Panel avg: 107d · This submission: 177d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code IYO System, Imaging, Pulsed Echo, Ultrasonic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1560
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Z&B Enterprises, Inc.
Rhona Shanker

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - IYO System, Imaging, Pulsed Echo, Ultrasonic

All 215
Devices cleared under the same product code (IYO) and FDA review panel - the closest regulatory comparables to K223287.
Velacur
K232459 · Sonic Incytes · Sep 2023
SiteRite™ 9 Ultrasound System
K231283 · Bard Access Systems, Inc. (C.R. Bard, Inc.) · Sep 2023
Bladder Scanner Model: BVT02
K223448 · Xuzhou Kaixin Electronic Instrument Co., Ltd. · Jul 2023
Butterfly iQ/iQ+ Ultrasound System
K220068 · Butterfly Network, Inc. · Mar 2023
FibroScan® device (Models: 502 Touch, 530 Compact, 430 Mini+, 230, and 630)
K223902 · Echosens · Mar 2023
Sunkingdom Ophthalmic Ultrasound Examination Instrument SK-3000A, SK-3000B, SK-3000C, SK-2000AP, SK-2000A, SK-2000P
K222787 · Chongqing Sunkingdom Medical Instrument Co., Ltd. · Jan 2023